These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36418469)

  • 1. Pharmaceutical and clinical studies of celecoxib topical hydrogel for management of chemotherapy-induced hand-foot syndrome.
    Shayeganmehr D; Ramezannia F; Gharib B; Rezaeilaal A; Shahi F; Jafariazar Z; Afshar M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1571-1581. PubMed ID: 36418469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of topical
    Mohajerani R; Shahi F; Jafariazar Z; Afshar M
    Cutan Ocul Toxicol; 2021 Sep; 40(3):257-262. PubMed ID: 34152880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study).
    Santhosh A; Kumar A; Pramanik R; Gogia A; Prasad CP; Gupta I; Gupta N; Cheung WY; Pandey RM; Sharma A; Batra A
    Trials; 2022 May; 23(1):420. PubMed ID: 35590388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials.
    Pandy JGP; Franco PIG; Li RK
    Support Care Cancer; 2022 Nov; 30(11):8655-8666. PubMed ID: 35655045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.
    Santhosh A; Sharma A; Bakhshi S; Kumar A; Sharma V; Malik PS; Pramanik R; Gogia A; Prasad CP; Sehgal T; Gund S; Dev A; Cheung WY; Pandey RM; Kumar S; Gupta I; Batra A;
    J Clin Oncol; 2024 May; 42(15):1821-1829. PubMed ID: 38412399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological prevention strategy for capecitabine-induced hand-foot syndrome: A network meta-analysis of randomized control trials.
    Kao YS; Lo CH; Tu YK; Hung CH
    Dermatol Ther; 2022 Oct; 35(10):e15774. PubMed ID: 36054263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study).
    Iimura Y; Furukawa N; Ishibashi M; Ahiko Y; Tanabe T; Aikou S; Shida D; Nojima M; Kuroda S; Boku N
    BMC Gastroenterol; 2022 Jul; 22(1):341. PubMed ID: 35836104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical non-occlusive polymers in hand-foot syndrome.
    Fabbrocini G; Cristaudo A; Ionescu MA; Panariello L; Robert G; Pellicano M; Ayala F
    G Ital Dermatol Venereol; 2018 Apr; 153(2):165-171. PubMed ID: 29564873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Elyasi S; Shojaee FSR; Allahyari A; Karimi G
    Phytother Res; 2017 Sep; 31(9):1323-1329. PubMed ID: 28635153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; a preliminary clinical study.
    Bozkurt Duman B; Kara B; Oguz Kara I; Demiryurek H; Aksungur E
    J BUON; 2011; 16(4):759-64. PubMed ID: 22331734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomised trials.
    Macedo LT; Lima JP; dos Santos LV; Sasse AD
    Support Care Cancer; 2014 Jun; 22(6):1585-93. PubMed ID: 24463616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Urea Cream on Hand-Foot Syndrome in Patients Receiving Chemotherapy: A Meta-analysis.
    Lan TC; Tsou PH; Tam KW; Huang TW
    Cancer Nurs; 2022 Sep-Oct 01; 45(5):378-386. PubMed ID: 34483284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Liu Y; May BH; Zhang AL; Guo X; Lu C; Xue CC; Zhang H
    Integr Cancer Ther; 2019; 18():1534735418817833. PubMed ID: 30526124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
    Yap YS; Kwok LL; Syn N; Chay WY; Chia JWK; Tham CK; Wong NS; Lo SK; Dent RA; Tan S; Mok ZY; Koh KX; Toh HC; Koo WH; Loh M; Ng RCH; Choo SP; Soong RCT
    JAMA Oncol; 2017 Nov; 3(11):1538-1545. PubMed ID: 28715540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study.
    Zhang RX; Wu XJ; Lu SX; Pan ZZ; Wan DS; Chen G
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):953-7. PubMed ID: 21113620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of EVOSKIN®Palm and sole moisturizing cream in treating capecitabine-associated hand-foot syndrome: a randomized double-blind clinical trial.
    Lu W; Huang Z; Chen S; Lv H; Chen X; Lei J; Ke C; Hong C; Wei Y; Su R; Chen R; Sun Z; Yang P; Tan X; Liu H
    Ann Palliat Med; 2021 Mar; 10(3):3009-3017. PubMed ID: 33849091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic and therapeutic efficacy of pyridoxine supplements in the management of hand-foot syndrome during chemotherapy: a meta-analysis.
    Jo SJ; Shin H; Jo S; Kwon O; Myung SK
    Clin Exp Dermatol; 2015 Apr; 40(3):260-70. PubMed ID: 25557587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03).
    Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Miura K; Oshio H; Ohori H; Ariyoshi K; Oyamada S; Iwase S
    Support Care Cancer; 2020 Aug; 28(8):3649-3657. PubMed ID: 31811480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evidence of prevention strategies for capecitabine-induced hand-foot syndrome.
    Huang XZ; Chen Y; Chen WJ; Zhang X; Wu CC; Wang ZN; Wu J
    Int J Cancer; 2018 Jun; 142(12):2567-2577. PubMed ID: 29355976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transethosomal Gel for the Topical Delivery of Celecoxib: Formulation and Estimation of Skin Cancer Progression.
    Abdellatif AAH; Aldosari BN; Al-Subaiyel A; Alhaddad A; Samman WA; Eleraky NE; Elnaggar MG; Barakat H; Tawfeek HM
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.